Surgical and oncological aspects

Before initiating therapy, GIST patients should be discussed at an interdisciplinary tumor board. For intermediate to high risk of relapse, adjuvant imatinib therapy should be considered after resection. Patients with metastatic GIST benefit from tyrosine kinase inhibitors and local measures.